BIODELIVERY SCIENCS (NASDAQ:BDSI)
4.12
0.04 (0.96%)
| BIODELIVERY SCIENCS (NASDAQ:BDSI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $4.16 | 52 Week High | $8.29 | ||
| Open | $4.14 | 52 Week Low | $2.11 | ||
| Day High | $4.26 | P/E | N/A | ||
| Day Low | $4.05 | EPS | $-1.53 | ||
| Volume | 103,258 | ||||
| More BDSI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CTIC | 2 | HBAN | 2 |
| JAZZ | 2 | AIG | 1 |
| CERS | 1 | AEZS | 1 |
| NDAQ | 1 | CHINA | 1 |
| CLZR | 1 | AIM | 1 |
| CIT | 1 | ENS | 1 |
Entities who have mentioned BDSI
- Ladenburg Thalmann Financial Services | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Facebook | View Related Stories »
- Twitter | View Related Stories »
- Natural Gas Inventories | View Related Stories »
- Crude Oil | View Related Stories »
- Deutsche Bank | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Roth Capital | View Related Stories »
- Robert W Baird | View Related Stories »
- Dividend | View Related Stories »
- Central Securities Corp. | View Related Stories »
- Lazard | View Related Stories »
View All ReportsStreetInsider.com Reports on BDSI
- BioDelivery Sciences (BDS) Announces $1.3M U.S. Army Grant
- BioDelivery Sciences (BDSI) Issued US Patent Extending Exclusivity for BEMA Delivery Technology
- Morning Movers 8/19: OTIX, ISR, CERS, CLZR, LZB, IPAS Higher; VTG, YGE, LFT, ENS, ADPI Lower
- BioDelivery Sciences (BDSI) Retains ICR to Assist Company's Shareholder Communications Program
- Baird Initiates Coverage on BioDelivery Sciences (BDSI) with an Outperform
View All Press ReleasesCompany Press Releases on BDSI
- BioDelivery Sciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
- BioDelivery Sciences International, Inc. (BDSI) President and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
- BioDelivery Sciences and Meda Launch ONSOLIS (fentanyl buccal soluble film)
- BioDelivery Sciences Receives $1.3 Million US Army Grant For Investigation of Bioral Amphotericin B in Topical Leishmaniasis
StreetInsider Reports on BDSI by Category
View All BlogsBlogs on BDSI
- Chelsea Therapeutics: There Are Safer Rebound Plays
- Four Biotech Stocks to Play the Sector Pullback
- BioDelivery Sciences Opportunity, Beware Cel Sci Bashers
- BioDelivery Sciences I sRestarting the Catalyst Cycle
- BDSI Insider Selling Was a Blessing for Investors
View All FilingsSEC Filings on BDSI
- Form 10-Q BIODELIVERY SCIENCES For: Sep 30
- Form 8-K BIODELIVERY SCIENCES For: Oct 08
- Form 8-K BIODELIVERY SCIENCES For: Oct 06
- Form 8-K BIODELIVERY SCIENCES For: Oct 02
Comments on recent BDSI articles
Comments on BDSI
No comments are currently available.
on Dec 15, 2008
at 06:57 PM BDSI Keep an eye on this one!
Article: BioDelivery Sciences (BDSI) Resubmits NDA for ONSOLIS(TM)